Jiangxi Synergy Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002P83
CNY
8.04
-0.1 (-1.23%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
751.06
718.48
717.52
590.31
433.92
411.63
265.76
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
751.06
718.48
717.52
590.31
433.92
411.63
265.76
Raw Material Cost
522.24
493.10
499.11
421.63
289.90
296.29
193.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
107.77
106.00
105.74
62.07
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
19.09
10.65
8.44
6.16
9.33
4.61
0.49
Selling and Distribution Expenses
59.67
52.78
45.06
39.93
25.55
26.08
34.09
Other Expenses
-7.14
-5.70
-5.81
-3.36
2.23
2.87
2.49
Total Expenditure (Excl Depreciation)
637.35
605.53
600.26
496.16
347.09
355.66
252.61
Operating Profit (PBDIT) excl Other Income
113.69999999999999
112.89999999999999
117.30000000000001
94.2
86.8
56
13.100000000000001
Other Income
44.15
29.00
4.90
4.88
2.60
0.70
15.03
Operating Profit (PBDIT)
248.48
192.19
181.73
145.83
139.72
99.01
50.68
Interest
19.09
10.65
8.44
6.16
9.33
4.61
0.49
Exceptional Items
0.18
0.35
-0.26
0.26
0.00
0.05
0.00
Gross Profit (PBDT)
228.82
225.38
218.41
168.68
144.02
115.34
72.59
Depreciation
114.77
69.39
66.88
51.58
52.33
42.77
23.86
Profit Before Tax
114.80
112.50
106.15
88.34
78.06
51.68
26.33
Tax
8.11
6.52
5.48
7.22
8.01
3.37
1.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
106.58
105.98
100.67
81.12
70.05
48.31
24.53
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
106.58
105.98
100.67
81.12
70.05
48.31
24.53
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
106.58
105.98
100.67
81.12
70.05
48.31
24.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,308.75
2,226.45
1,319.67
888.11
816.50
706.31
658.16
Earnings per share (EPS)
0.25
0.28
0.29
0.24
0.23
0.15
0.08
Diluted Earnings per share
0.25
0.28
0.29
0.24
0.23
0.15
0.08
Operating Profit Margin (Excl OI)
11.93%
13.06%
15.32%
15.14%
19.54%
13.49%
4.44%
Gross Profit Margin
30.57%
25.32%
24.12%
23.7%
30.05%
22.95%
18.88%
PAT Margin
14.19%
14.75%
14.03%
13.74%
16.14%
11.74%
9.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 4.54% vs 0.14% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 0.57% vs 5.26% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 25.18% vs -7.69% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 80.19% vs 26.19% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Jiangxi Synergy Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
751.06
0
751.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
751.06
0
751.06
Raw Material Cost
522.24
0
522.24
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
107.77
0
107.77
Power Cost
0
0
0.00
Manufacturing Expenses
19.09
0
19.09
Selling and Distribution Expenses
59.67
0
59.67
Other Expenses
-7.14
0.00
-7.14
Total Expenditure (Excl Depreciation)
637.35
0
637.35
Operating Profit (PBDIT) excl Other Income
113.72
0.00
113.72
Other Income
44.15
0
44.15
Operating Profit (PBDIT)
248.48
0
248.48
Interest
19.09
0
19.09
Exceptional Items
0.18
0
0.18
Gross Profit (PBDT)
228.82
0
228.82
Depreciation
114.77
0
114.77
Profit Before Tax
114.80
0
114.80
Tax
8.11
0
8.11
Provisions and contingencies
0
0
0.00
Profit After Tax
106.58
0
106.58
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
106.58
0
106.58
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
106.58
0
106.58
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,308.75
0
2,308.75
Earnings per share (EPS)
0.25
0
0.25
Diluted Earnings per share
0.25
0
0.25
Operating Profit Margin (Excl OI)
11.93%
0%
0.00
11.93%
Gross Profit Margin
30.57%
0%
0.00
30.57%
PAT Margin
14.19%
0%
0.00
14.19%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 75.11 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.54% vs 0.14% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 10.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.57% vs 5.26% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.43 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 25.18% vs -7.69% in Dec 2023

Annual - Interest
Interest 1.91 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 80.19% vs 26.19% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.93%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023